Intrathecal Drug Pumps for RSD: Targeted Pain Relief
Reflex Sympathetic Dystrophy (RSD), now commonly called Complex Regional Pain Syndrome (CRPS), can cause burning pain, extreme sensitivity, swelling, colour changes and restricted movement. When symptoms persist after an injury or surgery, everyday activities may become difficult and standard medicines may provide only partial relief.
An intrathecal drug pump is an implanted system that delivers small amounts of medicine into the fluid around the spinal cord. This targeted approach may be considered for carefully selected people with severe, long-lasting pain. It is a specialist treatment, not a cure, and decisions should be made with a pain physician, rehabilitation team and relevant medical specialists.
What An Intrathecal Pump Does
The pump is placed beneath the skin, usually in the abdomen, and connected to a thin catheter that enters the intrathecal space near the spinal cord. Medication travels directly to the nervous system, so much smaller doses may be used than with tablets or injections taken into the bloodstream.
Depending on the clinical situation, the pump may deliver medicines such as baclofen for muscle spasm or carefully selected analgesic and nerve-modulating drugs. The exact combination varies between patients, and some medications commonly used for general pain are unsuitable for intrathecal delivery.
The device has a refillable reservoir. A specialist service checks the pump and replenishes it at scheduled appointments, often every few weeks or months. Missing a refill can be dangerous, particularly when the medicine is essential for controlling severe spasticity or pain.
When Specialists Consider It
An implanted pump is generally considered only after less invasive treatments have been tried or found unsuitable. These may include physical therapy, graded activity, psychological support, nerve-pain medicines, topical treatments, sympathetic blocks and other interventional procedures.
The condition should be assessed carefully because RSD can overlap with nerve injury, inflammatory disorders, vascular problems and musculoskeletal disease. A trial of intrathecal medicine may be performed before permanent implantation to estimate whether pain, function or sleep improves enough to justify surgery.
In Australia, patients may be referred through a public hospital pain service or a private multidisciplinary clinic in cities such as Sydney, Melbourne, Brisbane or Perth. Waiting times, specialist availability and out-of-pocket costs can differ widely between states and between public and private care.
Assessment And Diagnosis
There is no single blood test or scan that confirms CRPS. Diagnosis is based on the history, physical examination and recognised clinical features, including disproportionate pain, allodynia, temperature or colour changes, sweating differences, swelling and altered movement.
Before considering a pump, clinicians usually review previous treatments, medication effects, mental health, mobility and the person’s ability to attend follow-up appointments. Imaging or nerve studies may help exclude other conditions, although normal results do not rule out CRPS.
Remote consultations can assist people living in regional and rural areas, especially for medication reviews and preparation for specialist appointments. However, telemedicine for RSD cannot replace every hands-on examination, procedure or rehabilitation assessment.
Potential Benefits And Limits
A successful intrathecal treatment may reduce pain intensity, improve sleep and make movement therapy more manageable. Some people value the possibility of reducing oral medicines that cause sedation, constipation, nausea or concentration problems.
The response is unpredictable. A pump may reduce pain without restoring normal strength or sensation, and it does not reverse the underlying nervous-system changes associated with CRPS. Benefits should be measured through practical goals, such as walking farther, completing personal care, returning to work duties or participating in physiotherapy.
Cost and access are also relevant. Device implantation, refills and specialist reviews may involve different arrangements under Medicare, private health insurance and state-based hospital systems. Patients should request a written estimate covering surgery, hospital care, programming, future refills and potential device replacement.
Risks And Ongoing Monitoring
Possible complications include infection, bleeding, spinal-fluid leakage, catheter movement, pump malfunction and problems related to the medicine itself. Sudden interruption can cause serious withdrawal effects in some cases, while excessive delivery may lead to dangerous sedation, breathing problems or weakness.
Regular monitoring is essential. New fever, redness or discharge near the pump, severe headache, sudden loss of pain control, unusual drowsiness, breathing difficulty or rapidly changing neurological symptoms require urgent medical attention.
People should tell every treating professional about the implant. This includes emergency clinicians, dentists, surgeons and physiotherapists. They should also ask about MRI compatibility, travel arrangements and what to do if a refill appointment is delayed. Buying medicines from online medicine sources can create additional risks involving counterfeit products, incorrect strengths and interactions, so any online product should be discussed with a pharmacist or doctor before use.
Rehabilitation And Daily Life
A pump works best as part of a broader rehabilitation plan. Physiotherapy may focus on desensitisation, range of motion, strength, balance and gradual use of the affected limb. Occupational therapists can suggest equipment and pacing strategies for work, driving, cooking and household tasks.
Psychological care is also relevant, not because the pain is imagined, but because persistent pain can affect sleep, mood, confidence and social connection. Cognitive behavioural therapy, acceptance-based approaches and pain education may help people respond to flare-ups without abandoning movement altogether.
Australian weather can influence symptoms for some individuals, with heat, cold and humidity affecting comfort in places such as tropical Queensland or cooler Tasmania. Planning, hydration, suitable clothing and access to air conditioning may make daily routines more manageable, while travel between remote communities and metropolitan clinics requires additional medication and appointment planning.
Practical Safety Checks
Before proceeding, a patient and care team should establish realistic goals and a clear follow-up pathway. Useful points to document include:
- The expected improvement in pain, sleep, movement and daily function
- The medicine being trialled and possible side effects
- Who will manage refills, programming and after-hours concerns
- How surgery, device checks and complications will be funded
- Whether MRI scans, air travel and other procedures require special precautions
After implantation, everyday safety depends on consistent monitoring and communication. Keep a record of appointments, device information and current medicines, and carry the implant identification details when travelling or attending a new clinic. Important ongoing habits include:
- Attend every scheduled refill and programming appointment
- Report infection signs, sudden weakness or unexpected sedation promptly
- Avoid changing medicines or doses without specialist advice
- Continue agreed physiotherapy and pacing activities
- Tell clinicians about the pump before scans, surgery or emergency treatment
An intrathecal pump may provide targeted pain relief for a small, carefully assessed group of people with severe RSD or CRPS. It should be viewed as one part of long-term care, alongside rehabilitation, medication review, emotional support and practical planning.
Anyone considering this option should arrange a discussion with a GP and a multidisciplinary pain service. Bring a medication list, treatment history and specific functional goals so the specialist team can explain whether a trial, implantation or another approach is appropriate.